| abstract |
The invention relates to benzothiophene, benzofuran and indolthiazepinones, oxazepinones and diazepinones, in which the substituents are as defined in the description and to methods of silencing. The compounds are administered as agents to suppress leukocyte adherence to the vascular endothelium and as effective therapeutic agents for the treatment of inflammatory diseases. In addition, they inhibit the activity of human immunodeficiency virus (HIV). </P> |